Skip to main content
Trials logoLink to Trials
. 2016 Jul 20;17:333. doi: 10.1186/s13063-016-1502-2

Erratum to: ‘Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial’

Sadie Wickwar 1,2, Hayley McBain 1,3, Stanton P Newman 1, Shashivadan P Hirani 1, Catherine Hurt 1, Nicola Dunlop 2, Chris Flood 1, Daniel G Ezra 2,
PMCID: PMC4955264  PMID: 27439615

Erratum

Unfortunately, the original version of this article [1] contained an error. In the Trial registration section the Clinicaltrials.ogv ID was included incorrectly as NCT102577224. The Correct ID is NCT02577224. There will also be an update to correct this error.

Footnotes

The online version of the original article can be found under doi:10.1186/s13063-016-1263-y.

Reference

  • 1.Wickwar S, McBain H, Newman SP, Hirani SP, Hurt C, Dunlop N, Flood C, Ezra DG. Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial. Trials. 2016;17:129. doi: 10.1186/s13063-016-1263-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES